Evidence map›Paper›PMID 39941209›Full record

ArticleDiagnostics (Basel, Switzerland)2025

Predicting Drug Resistance in

Guillermo Paredes-Gutierrez, Ricardo Perea-Jacobo, Héctor-Gabriel Acosta-Mesa, Efren Mezura-Montes, José Luis Morales Reyes, Roberto Zenteno-Cuevas, Miguel-Ángel Guerrero-Chevannier, Raquel Muñiz-Salazar, Dora-Luz Flores

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. A Comprehensive Review of Genetic Mechanisms ofInfection and drug resistance · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Guillermo Paredes-GutierrezFacultad de Ingeniería Arquitectura y Diseño, Universidad Autónoma de Baja California, Campus Ensenada, Ensenada 22860, Mexico.ORCID 0000-0002-8519-7126
Ricardo Perea-JacoboFacultad de Ingeniería Arquitectura y Diseño, Universidad Autónoma de Baja California, Campus Ensenada, Ensenada 22860, Mexico.ORCID 0000-0003-4164-7719
Héctor-Gabriel Acosta-MesaInstituto de Investigaciones en Inteligencia Artificial, Universidad Veracruzana, Xalapa 91097, Mexico.ORCID 0000-0002-0935-7642
Efren Mezura-MontesInstituto de Investigaciones en Inteligencia Artificial, Universidad Veracruzana, Xalapa 91097, Mexico.ORCID 0000-0002-1565-5267
José Luis Morales ReyesCentro de Investigación en Alimentos y Desarrollo, Universidad Veracruzana, Xalapa 91190, Mexico.ORCID 0000-0003-2034-8509
Roberto Zenteno-CuevasInstituto de Salud Pública, Universidad Veracruzana, Xalapa 91097, Mexico.ORCID 0000-0001-9597-127X
Miguel-Ángel Guerrero-ChevannierFacultad de Ingeniería Arquitectura y Diseño, Universidad Autónoma de Baja California, Campus Ensenada, Ensenada 22860, Mexico.ORCID 0000-0002-2545-1209
Raquel Muñiz-SalazarEscuela de Ciencias de la Salud, Universidad Autónoma de Baja California, Campus Ensenada, Ensenada 22890, Mexico.ORCID 0000-0001-5528-7772
Dora-Luz FloresFacultad de Ingeniería Arquitectura y Diseño, Universidad Autónoma de Baja California, Campus Ensenada, Ensenada 22860, Mexico.ORCID 0000-0002-2623-3772

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

drug resistanceextreme gradient boostingMycobacterium tuberculosisvariant call format

Identifiers

PMID39941209
PMCPMC11817661

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.